KR830002502A - 악성 종양의 진단 검사방법 - Google Patents

악성 종양의 진단 검사방법 Download PDF

Info

Publication number
KR830002502A
KR830002502A KR1019800001518A KR800001518A KR830002502A KR 830002502 A KR830002502 A KR 830002502A KR 1019800001518 A KR1019800001518 A KR 1019800001518A KR 800001518 A KR800001518 A KR 800001518A KR 830002502 A KR830002502 A KR 830002502A
Authority
KR
South Korea
Prior art keywords
cancer
inhibitory protein
bleomycin
determination
concentration
Prior art date
Application number
KR1019800001518A
Other languages
English (en)
Korean (ko)
Inventor
티. 크루크 스탠리
갈반 루이스
Original Assignee
알푸스 오. 죤슨
배일러칼리지 어넌 메디슨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알푸스 오. 죤슨, 배일러칼리지 어넌 메디슨 filed Critical 알푸스 오. 죤슨
Publication of KR830002502A publication Critical patent/KR830002502A/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1019800001518A 1979-04-10 1980-04-10 악성 종양의 진단 검사방법 KR830002502A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10
US28732 1979-04-10

Publications (1)

Publication Number Publication Date
KR830002502A true KR830002502A (ko) 1983-05-30

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800001518A KR830002502A (ko) 1979-04-10 1980-04-10 악성 종양의 진단 검사방법

Country Status (24)

Country Link
JP (1) JPS55143441A (sv)
KR (1) KR830002502A (sv)
AR (1) AR222700A1 (sv)
AT (1) AT365343B (sv)
AU (1) AU536522B2 (sv)
BE (1) BE882669A (sv)
CH (1) CH644453A5 (sv)
DE (1) DE3013837A1 (sv)
DK (1) DK149980A (sv)
ES (1) ES490396A0 (sv)
FI (1) FI801078A (sv)
FR (1) FR2454099A1 (sv)
GB (1) GB2047712B (sv)
GR (1) GR67692B (sv)
HU (1) HU183122B (sv)
IE (1) IE49981B1 (sv)
IL (1) IL59772A (sv)
IT (1) IT1143135B (sv)
LU (1) LU82345A1 (sv)
NL (1) NL8002094A (sv)
NO (1) NO801018L (sv)
PH (1) PH15637A (sv)
SE (1) SE8002602L (sv)
ZA (1) ZA802141B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
AU536522B2 (en) 1984-05-10
AU5719380A (en) 1980-10-16
GB2047712B (en) 1983-02-23
FR2454099B1 (sv) 1984-01-27
HU183122B (en) 1984-04-28
IE800693L (en) 1980-10-10
NL8002094A (nl) 1980-10-14
DK149980A (da) 1980-10-11
FI801078A (fi) 1980-10-11
GB2047712A (en) 1980-12-03
DE3013837A1 (de) 1980-10-30
ZA802141B (en) 1981-04-29
SE8002602L (sv) 1980-12-09
ES8103380A1 (es) 1981-02-16
ATA195780A (de) 1981-05-15
AT365343B (de) 1982-01-11
IT1143135B (it) 1986-10-22
NO801018L (no) 1980-10-13
ES490396A0 (es) 1981-02-16
IT8048370A0 (it) 1980-04-09
FR2454099A1 (fr) 1980-11-07
GR67692B (sv) 1981-09-07
IE49981B1 (en) 1986-01-22
IL59772A (en) 1983-05-15
AR222700A1 (es) 1981-06-15
PH15637A (en) 1983-03-11
IL59772A0 (en) 1980-06-30
JPS55143441A (en) 1980-11-08
BE882669A (fr) 1980-10-06
CH644453A5 (fr) 1984-07-31
LU82345A1 (fr) 1980-12-16

Similar Documents

Publication Publication Date Title
牧村進 et al. Quantitative determination of bovine serum Haptoglobin and its elevation in some inflammatory diseases.
Biewenga et al. Lactate dehydrogenase isoenzyme (s) linked to IgA immunoglobulin in a patient with a myocardial infarction
Olsson et al. Gamma globulins of CSF and serum in multiple sclerosis: isoelectric focusing on polyacrylamide gel and agar gel electrophoresis
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
Ogawa et al. Dynein 2. A new adenosine triphosphatase from sea urchin sperm flagella.
Searcy et al. A study of the specificity of the Berthelot colour reaction
ES516987A0 (es) Un procedimiento para la determinacion cuantitativa del factor xii de coagulacion de la sangre en el plasma sanguineo humano.
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
Dyce et al. SERUM TRYPSIN INHIBITORS IN THE NORMAL AND IN PATIENTS WITH ACUTE PANCREATITIS.
Dunlap et al. Interconversion of the multiple forms of dihydrofolate reductase from amethopterin-resistant Lactobacillus casei
Titus et al. Plasma aminopeptidase activity (oxytocinase) in pregnancy and labor
ATE38521T1 (de) Neues protein (pp13), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung.
KR830002502A (ko) 악성 종양의 진단 검사방법
Brackexridge The tyrosine and tryptophan content of blood serum in malignant disease
Omoto et al. The distribution of the group-specific component (Gc) subtypes in Japanese
McCombs et al. A new ceruloplasmin variant, Cp Galveston
Yatzidis et al. An improved method for the simple and accurate colorimetric determination of urea with Ehrlich's reagent
Mager et al. The use of cellulose acetate for the electrophoretic separation and quantitation of serum lactic dehydrogenase isozymes in normal and pathologic states
Williams An evaluation of the Casoni test in human hydatidosis using an antigen solution of low nitrogen concentration
Engle Jr et al. Separation of human hemoglobins by starch-gel zone electrophoresis
Titkov et al. HLA antigens in borderline and essential hypertension
Edwards et al. Hemoglobins of two urodeles: changes with metamorphosis
EA199800087A1 (ru) Промежуточное соединение для получения артропоцидного оксадиазина
Friedman et al. Characteristics of an inherited tumor-inducing factor in Drosophila melanogaster
Gibbs Effect of blood on the assay of 6-phosphogluconate dehydrogenase in vaginal fluid